Related Experiment Video
Updated: Nov 11, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal
Amanda M Vanderplow1, Andrew L Eagle2, Bailey A Kermath1
1Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Abstract:
The Akt family of kinases exerts many of its cellular effects via the activation of the mammalian target of rapamycin (mTOR) kinase through a series of intermediary proteins. Multiple lines of evidence have identified Akt-family kinases as candidate schizophrenia and bipolar disorder genes. Although dysfunction of the prefrontal cortex (PFC) is a key feature of both schizophrenia and bipolar disorder, no studies have comprehensively assessed potential alterations in Akt-mTOR pathway activity in the PFC of either disorder. Here, we examined the activity and expression profile of key proteins in the Akt-mTOR pathway in bipolar disorder and schizophrenia homogenates from two different PFC subregions. Our findings identify reduced Akt-mTOR PFC signaling in a subset of bipolar disorder subjects. Using a reverse-translational approach, we demonstrated that Akt hypofunction in the PFC is sufficient to give rise to key cognitive phenotypes that are paralleled by alterations in synaptic connectivity and function.
Insights
Reduced Akt-mammalian target of rapamycin (mTOR) pathway signaling in the prefrontal cortex (PFC) is linked to bipolar disorder. Akt hypofunction in the PFC can cause cognitive deficits and alter synaptic function.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Akt-family kinases are implicated in schizophrenia and bipolar disorder.
- Prefrontal cortex (PFC) dysfunction is central to these disorders.
- Akt-mammalian target of rapamycin (mTOR) pathway alterations in the PFC remain understudied in bipolar disorder and schizophrenia.
Purpose of the Study:
- To investigate Akt-mTOR pathway activity and protein expression in the PFC of individuals with bipolar disorder and schizophrenia.
- To explore the functional consequences of reduced Akt signaling in the PFC.
Main Methods:
- Analysis of key Akt-mTOR pathway proteins in postmortem PFC homogenates from bipolar disorder and schizophrenia subjects.
- Utilizing a reverse-translational approach to model Akt hypofunction in the PFC.
Main Results:
- Identified reduced Akt-mTOR signaling in the PFC of a subset of bipolar disorder patients.
- Demonstrated that Akt hypofunction in the PFC can induce cognitive phenotypes.
- Observed associated alterations in synaptic connectivity and function due to Akt hypofunction.
Conclusions:
- Akt-mTOR pathway dysregulation in the PFC may contribute to the pathophysiology of bipolar disorder.
- PFC Akt hypofunction is sufficient to model key cognitive and synaptic deficits observed in psychiatric disorders.
More Related Videos
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
08:42Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...